↓ Skip to main content

Cochrane Database of Systematic Reviews

Dopamine agonists for the treatment of restless legs syndrome

Overview of attention for article published in Cochrane database of systematic reviews, March 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
facebook
2 Facebook pages
wikipedia
6 Wikipedia pages

Citations

dimensions_citation
111 Dimensions

Readers on

mendeley
116 Mendeley
connotea
1 Connotea
Title
Dopamine agonists for the treatment of restless legs syndrome
Published in
Cochrane database of systematic reviews, March 2011
DOI 10.1002/14651858.cd006009.pub2
Pubmed ID
Authors

Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann, Magdolna Hornyak

Abstract

According to clinical guidelines, dopamine agonists are the first-line treatment of restless legs syndrome (RLS).

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Unknown 115 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 16%
Researcher 13 11%
Student > Ph. D. Student 11 9%
Student > Doctoral Student 8 7%
Student > Bachelor 8 7%
Other 21 18%
Unknown 36 31%
Readers by discipline Count As %
Medicine and Dentistry 40 34%
Nursing and Health Professions 7 6%
Agricultural and Biological Sciences 6 5%
Psychology 6 5%
Social Sciences 5 4%
Other 12 10%
Unknown 40 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2024.
All research outputs
#6,782,944
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#7,921
of 11,499 outputs
Outputs of similar age
#36,349
of 119,179 outputs
Outputs of similar age from Cochrane database of systematic reviews
#55
of 97 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 119,179 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.